AstraZeneca Plc on Monday reported Phase 3 EMERALD-3 trial results showing that its immunotherapy-based STRIDE regimen, when ...
A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...
Health and Me on MSN
Ozempic-like weight-loss drugs may cut breast cancer risk by a third, finds research
Breast cancer is the leading cause of cancer mortality among women worldwide and the most common cancer diagnosed overall, ...
By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than ...
10hon MSN
Engineered Salmonella deliver cancer-killing viruses, shrinking liver and pancreatic tumors in mice
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results